Azadeh Esmaeili, MD
Pathology · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 5
Offices
5 locations
Looking this up.
Hospitals listed: Alta Bates Summit Medical Center · Alta Bates Summit Medical Center - Alta Bates Camp. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Esmaeili’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A181222 · Current
Licensed to practise in California · since 2022 · expires 2028-08-31 · Kerman University of Medical Sciences and Health Services.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.09 (87.72 to 172.46) · 109 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.227 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.94) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.6 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.8 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 341 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 381 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 2,811 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 7,167 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,659 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.93 (0.92 to 4.94) · 1,668 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.25 (0 to 2.75) · 580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (1.19 to 4.15) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.17 (0.33 to 12.02) · 633 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.11 (4.67 to 11.55) · 619 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.07) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 6,085 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 217 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.724 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.425 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 416 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 606 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.4 · 359 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.8 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.4 · 358 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 382 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.3 to 16) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.8 (11.1 to 20) · 251 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 579 cases | No different | Jan 2024 – Dec 2024 |
What patients said (535 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$188,519
Medicare paid this office $188,519 for 957 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Pathology examination of tissue using a microscope, intermediate complexity | 358 | $82,825 | $70 |
| Special stained specimen slides to examine tissue, each additional procedure | 177 | $22,770 | $25 |
| Pathology examination of tissue using a microscope, intermediate complexity | 366 | $19,484 | $32 |
| Special stained specimen slides to examine tissue, initial procedure | 235 | $9,802 | $31 |
| Pathology examination of tissue using a microscope, moderately high complexity | 66 | $6,724 | $73 |
See all 28 services
| Pathology examination of tissue using a microscope, intermediate complexity | 358 | $82,825 | $70 |
| Special stained specimen slides to examine tissue, each additional procedure | 177 | $22,770 | $25 |
| Pathology examination of tissue using a microscope, intermediate complexity | 366 | $19,484 | $32 |
| Special stained specimen slides to examine tissue, initial procedure | 235 | $9,802 | $31 |
| Pathology examination of tissue using a microscope, moderately high complexity | 66 | $6,724 | $73 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure | 35 | $5,715 | $37 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 60 | $4,876 | $74 |
| Microscopic genetic analysis of tumor, manual | 44 | $4,048 | $37 |
| Special stained specimen slides to examine tissue, initial procedure | 83 | $3,838 | $31 |
| Bone marrow, smear interpretation | 64 | $3,205 | $43 |
| Special stained specimen slides to examine tissue including interpretation and report | 65 | $2,429 | $11 |
| Genetic sequencing localization, initial procedure | 43 | $2,391 | $38 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 14 | $2,206 | $158 |
| Cell examination of specimen, selective cellular enhancement technique | 64 | $2,006 | $24 |
| Special stained specimen slides to examine tissue, each additional procedure | 27 | $1,962 | $25 |
| Evaluation of fine needle aspirate with interpretation and report | 26 | $1,869 | $60 |
| Special stained specimen slides to identify organisms including interpretation and report | 28 | $1,553 | $24 |
| Genetic sequencing localization, each additional procedure | 33 | $1,497 | $30 |
| Preparation of tissue for examination by removing any calcium present | 118 | $1,421 | $11 |
| Evaluation of fine needle aspirate | 25 | $1,041 | $32 |
| Pathology cytologic examination of specimen during surgery, initial site | 12 | $823 | $55 |
| Cell examination of specimen, selective cellular enhancement technique | 28 | $734 | $24 |
| Special stained specimen slides to identify organisms including interpretation and report | 18 | $703 | $23 |
| Pathology examination of tissue using a microscope, moderately low complexity | 54 | $562 | $10 |
| Pap test | 22 | $531 | $23 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure | 15 | $492 | $29 |
| Pathology examination of tissue using a microscope, limited examination | 49 | $225 | $4 |
| X-ray of surgical specimen | 11 | $189 | $13 |
Who their Medicare patients are
957 Original Medicare patients in 2024. Average age 74 · Under 65 5% · 85 and older 11% · Women 58% · Also on Medicaid 28% · Health risk score 1.41. At or below the middle of the specialty; the typical pathology clinician is at 1.55.
Conditions among them: High blood pressure 69% · Diabetes 27% · Chronic kidney disease 26% · Cancer 25% · Coronary heart disease 22% · Depression 21% · Heart failure 17% · Atrial fibrillation 17% · COPD 13% · Stroke 9% · Dementia 6%.
The office billed $698,579, Medicare allowed $238,635 and paid $188,519; for 4,745 services of 33 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 957 | 4,745 | 74 | 1.41 | $698,579 | $188,519 |
| 2023 | 815 | 4,785 | 74 | 1.64 | $593,449 | $160,634 |
| 2022 | 170 | 1,143 | 74 | 1.46 | $123,194 | $33,709 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 25 services
| Special stained specimen slides to examine tissue, each additional procedure | 231 | $30,822 | $25 |
| Pathology examination of tissue using a microscope, intermediate complexity | 478 | $30,386 | $33 |
| Pathology examination of tissue using a microscope, intermediate complexity | 152 | $28,350 | $69 |
| Special stained specimen slides to examine tissue, initial procedure | 303 | $13,381 | $31 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 81 | $7,466 | $75 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure | 42 | $7,069 | $38 |
| Pathology examination of tissue using a microscope, moderately high complexity | 68 | $6,949 | $74 |
| Bone marrow, smear interpretation | 85 | $4,379 | $43 |
| Special stained specimen slides to examine tissue including interpretation and report | 97 | $3,478 | $11 |
| Genetic sequencing localization, initial procedure | 62 | $3,393 | $39 |
| Evaluation of fine needle aspirate with interpretation and report | 30 | $3,016 | $63 |
| Microscopic genetic analysis of tumor, manual | 40 | $2,950 | $37 |
| Pathology examination of tissue using a microscope, high complexity | 15 | $2,612 | $131 |
| Preparation of tissue for examination by removing any calcium present | 182 | $2,173 | $11 |
| Cell examination of specimen, selective cellular enhancement technique | 60 | $1,773 | $25 |
| Genetic sequencing localization, each additional procedure | 44 | $1,767 | $30 |
| Pathology examination of specimen during surgery, first tissue block | 14 | $1,736 | $56 |
| Evaluation of fine needle aspirate | 27 | $1,347 | $31 |
| Special stained specimen slides to examine tissue, initial procedure | 31 | $1,185 | $31 |
| Pathology cytologic examination of specimen during surgery, initial site | 14 | $1,062 | $56 |
| Special stained specimen slides to identify organisms including interpretation and report | 28 | $994 | $24 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure | 29 | $944 | $30 |
| Pathology examination of tissue using a microscope, moderately low complexity | 84 | $888 | $10 |
| Screening examination of specimen cells, preparation, screening and interpretation | 12 | $298 | $23 |
| Pathology examination of tissue using a microscope, limited examination | 32 | $132 | $4 |
2022: 14 services
| Special stained specimen slides to examine tissue, each additional procedure | 55 | $8,423 | $25 |
| Pathology examination of tissue using a microscope, intermediate complexity | 121 | $7,588 | $34 |
| Special stained specimen slides to examine tissue, initial procedure | 74 | $3,011 | $31 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure | 14 | $2,578 | $38 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 29 | $2,375 | $74 |
| Bone marrow, smear interpretation | 27 | $1,200 | $43 |
| Genetic sequencing localization, initial procedure | 20 | $1,091 | $39 |
| Special stained specimen slides to examine tissue including interpretation and report | 30 | $1,031 | $11 |
| Genetic sequencing localization, each additional procedure | 19 | $982 | $31 |
| Preparation of tissue for examination by removing any calcium present | 53 | $599 | $11 |
| Cell examination of specimen, selective cellular enhancement technique | 19 | $471 | $24 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure | 11 | $327 | $30 |
| Pathology examination of tissue using a microscope, moderately low complexity | 22 | $224 | $10 |
| Pathology examination of tissue using a microscope, limited examination | 15 | $62 | $4 |
Medicaid work
$7,545 in 2024
Medicaid paid $7,545 for 283 billed services this clinician did in 2024, up to 27 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| TISSUE EXAM BY PATHOLOGIST | 152 | $3,773 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 82 | $1,730 |
| TISSUE EXAM BY PATHOLOGIST | 37 | $1,654 |
| IMHCHEM/IMCYTCHM EA ADD ANTB | 12 | $388 |
| 2024 | 283 | 4 | 27 | $7,545 |
| 2023 | 524 | 4 | 25 | $11,849 |
| 2022 | 37 | 1 | 21 | $419 |
See the largest Medicaid services in earlier years
2023
| TISSUE EXAM BY PATHOLOGIST | 278 | $5,437 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 157 | $2,710 |
| IMHCHEM/IMCYTCHM EA ADD ANTB | 61 | $2,417 |
| TISSUE EXAM BY PATHOLOGIST | 28 | $1,285 |
2022
| TISSUE EXAM BY PATHOLOGIST | 37 | $419 |
Money from drug and device companies
$125 in 2024
A payment is not proof that care is biased.
| ANI Pharmaceuticals | Purified Cortrophin Gel | $125 | 1 payment
|
See the published payment
| ANI Pharmaceuticals | Meals · 2024-05-31 | Purified Cortrophin Gel | $125 |
Professional record
- NPI
- 1386198489
- Licence
- CA A181222California A181222: Current · expires 2028-08-31
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207ZP0102X (207ZP0102X)
- Mailing address
- 2510 Webster St, Berkeley, CA, 94705
- NPI first listed
- 2016-08-08
- NPI last updated
- 2025-01-03
- NPI record certified
- 2025-01-03
This is when the NPI record was last certified, not a medical board exam.